Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 969 of 1,261

  1. US 7914780

    Aminopeptidase A (APA) targeting peptides for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  2. US 7914788

    Monoclonal antibodies against orthopoxviruses

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  3. US 7915036

    Compositions comprising T cell receptors and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  4. WO 2011033094

    CALENDRIER DE L'ADMINISTRATION DE DÉRIVÉS DE BENZAZOLE DANS LE TRAITEMENT DE LEUCÉMIES

    4SC AG [DE] · Granted Mar 24, 2011 · Expires Mar 19, 2031

    granted

  5. US 7908729

    Method for making a lollipop

    TEVA WOMEN'S HEALTH, INC. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  6. US 7910131

    Method of treating seizures using modified release formulations of oxcarbazepine

    Supernus Pharmaceuticals, Inc. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  7. US 7910126

    Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same

    TEVA WOMEN'S HEALTH, INC. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  8. US 7910661

    Thiol-selective water-soluble polymer derivatives

    Nektar Therapeutics · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  9. US 7910621

    Small molecule antagonists of XIAP family proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  10. US 7910608

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  11. US 7910587

    Quinoxalinyl dipeptide hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  12. US 7910546

    Methods and compositions for the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  13. US 7910692

    Immunogenic peptides and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  14. US 7910128

    Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics

    Supernus Pharmaceuticals, Inc. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  15. US 7910299

    Methods for diagnosing systemic lupus erythematosus

    Regents of the University of Minnesota · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  16. US 7910105

    Methods for treating and preventing fibrosis

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  17. US 7910323

    Methods for identifying the effect of a drug agent on the metabolism of sugars and fats in an individual

    The Regents of the University of California · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  18. US 2011062165

    BALANCED INDIVIDUAL DINING PLATE

    ALLERGAN INC [US] · Granted Mar 17, 2011 · Expires Mar 12, 2031

    granted

  19. US 7906104

    Methods for detecting pancreatic beta-islet cells and diseases thereof

    The Regents of the University of California · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  20. US 7906555

    Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  21. US 7906292

    Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  22. US 7906650

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  23. US 7906523

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  24. US 7906513

    Hydrazide-containing hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.